News and Press Releases

Medera's Sardocor Granted FDA Orphan Drug Designation for DMD-associated Cardiomyopathy Gene Therapy
February 28, 2024

Medera's Sardocor Announces Fast Track Designation and Dosing of 3 Patients in First-in-Human HFpEF Gene Therapy Trial
February 14, 2024

Medera's Sardocor Announces FDA Clearance of IND for First-in-Human Gene Therapy Clinical Trial for DMD Cardiomyopathy
December 1, 2022

Medera Receives FDA Clearance for a First-In-Human Gene Therapy Trial for Heart Failure with Preserved Ejection Fraction (HFpEF)
November 18, 2022